Jinxin Fertility Group Past Earnings Performance
Past criteria checks 4/6
Jinxin Fertility Group's earnings have been declining at an average annual rate of -6.3%, while the Healthcare industry saw earnings growing at 9% annually. Revenues have been growing at an average rate of 16.5% per year. Jinxin Fertility Group's return on equity is 3.1%, and it has net margins of 10.7%.
Key information
-6.3%
Earnings growth rate
-11.6%
EPS growth rate
Healthcare Industry Growth | 11.3% |
Revenue growth rate | 16.5% |
Return on equity | 3.1% |
Net Margin | 10.7% |
Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
Recent updates
Returns On Capital Signal Tricky Times Ahead For Jinxin Fertility Group (HKG:1951)
Jan 06Jinxin Fertility Group (HKG:1951) Has A Pretty Healthy Balance Sheet
Dec 09Is Now The Time To Look At Buying Jinxin Fertility Group Limited (HKG:1951)?
Nov 13Jinxin Fertility Group Limited's (HKG:1951) 30% Jump Shows Its Popularity With Investors
Sep 27Is Jinxin Fertility Group (HKG:1951) A Risky Investment?
Sep 02Jinxin Fertility Group (HKG:1951) Will Want To Turn Around Its Return Trends
May 30After Leaping 25% Jinxin Fertility Group Limited (HKG:1951) Shares Are Not Flying Under The Radar
May 13These 4 Measures Indicate That Jinxin Fertility Group (HKG:1951) Is Using Debt Reasonably Well
May 05What Is Jinxin Fertility Group Limited's (HKG:1951) Share Price Doing?
Mar 12Capital Allocation Trends At Jinxin Fertility Group (HKG:1951) Aren't Ideal
Feb 14With Jinxin Fertility Group Limited (HKG:1951) It Looks Like You'll Get What You Pay For
Dec 25What Does Jinxin Fertility Group Limited's (HKG:1951) Share Price Indicate?
Dec 08Jinxin Fertility Group (HKG:1951) Is Reinvesting At Lower Rates Of Return
Oct 22Jinxin Fertility Group (HKG:1951) Takes On Some Risk With Its Use Of Debt
Sep 20What Does Jinxin Fertility Group Limited's (HKG:1951) Share Price Indicate?
Sep 04Are Investors Undervaluing Jinxin Fertility Group Limited (HKG:1951) By 43%?
May 30Is Now The Time To Look At Buying Jinxin Fertility Group Limited (HKG:1951)?
Apr 20An Intrinsic Calculation For Jinxin Fertility Group Limited (HKG:1951) Suggests It's 34% Undervalued
Feb 27Is There Now An Opportunity In Jinxin Fertility Group Limited (HKG:1951)?
Jan 09Jinxin Fertility Group (HKG:1951) Has A Pretty Healthy Balance Sheet
Dec 11Some Investors May Be Worried About Jinxin Fertility Group's (HKG:1951) Returns On Capital
Nov 28Jinxin Fertility Group Limited (HKG:1951) Shares Could Be 41% Below Their Intrinsic Value Estimate
Nov 03Is Jinxin Fertility Group Limited (HKG:1951) Potentially Undervalued?
Oct 04Jinxin Fertility Group (HKG:1951) Has A Pretty Healthy Balance Sheet
Sep 07Is There Now An Opportunity In Jinxin Fertility Group Limited (HKG:1951)?
Jun 06Jinxin Fertility Group (HKG:1951) Has A Rock Solid Balance Sheet
Apr 05What Does Jinxin Fertility Group Limited's (HKG:1951) Share Price Indicate?
Feb 25The Returns On Capital At Jinxin Fertility Group (HKG:1951) Don't Inspire Confidence
Jan 21Why Jinxin Fertility Group Limited (HKG:1951) Could Be Worth Watching
Nov 15Jinxin Fertility Group (HKG:1951) Seems To Use Debt Quite Sensibly
Oct 11Returns On Capital At Jinxin Fertility Group (HKG:1951) Paint A Concerning Picture
Sep 28Jinxin Fertility Group Limited's (HKG:1951) Intrinsic Value Is Potentially 44% Above Its Share Price
Sep 15Should You Think About Buying Jinxin Fertility Group Limited (HKG:1951) Now?
Jul 20Is Jinxin Fertility Group (HKG:1951) A Risky Investment?
Jun 29Are Jinxin Fertility Group Limited (HKG:1951) Investors Paying Above The Intrinsic Value?
Jun 09What Type Of Shareholders Make Up Jinxin Fertility Group Limited's (HKG:1951) Share Registry?
Mar 15Are Jinxin Fertility Group Limited (HKG:1951) Investors Paying Above The Intrinsic Value?
Feb 22Revenue & Expenses Breakdown
How Jinxin Fertility Group makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Jun 24 | 2,899 | 311 | 700 | 22 |
31 Mar 24 | 2,844 | 328 | 687 | 22 |
31 Dec 23 | 2,789 | 345 | 673 | 22 |
30 Sep 23 | 2,675 | 250 | 659 | 23 |
30 Jun 23 | 2,560 | 155 | 644 | 23 |
31 Mar 23 | 2,462 | 138 | 627 | 20 |
31 Dec 22 | 2,364 | 121 | 610 | 17 |
30 Sep 22 | 2,241 | 248 | 535 | 14 |
30 Jun 22 | 2,118 | 374 | 460 | 10 |
31 Mar 22 | 1,978 | 357 | 425 | 11 |
31 Dec 21 | 1,839 | 340 | 389 | 11 |
30 Sep 21 | 1,756 | 316 | 382 | 11 |
30 Jun 21 | 1,674 | 291 | 376 | 12 |
31 Mar 21 | 1,550 | 271 | 346 | 12 |
31 Dec 20 | 1,426 | 252 | 317 | 11 |
30 Sep 20 | 1,448 | 304 | 301 | 12 |
30 Jun 20 | 1,469 | 356 | 286 | 12 |
31 Mar 20 | 1,559 | 383 | 280 | 13 |
31 Dec 19 | 1,648 | 410 | 274 | 13 |
30 Sep 19 | 1,475 | 339 | 220 | 13 |
30 Jun 19 | 1,301 | 269 | 166 | 12 |
31 Mar 19 | 1,112 | 218 | 135 | 12 |
31 Dec 18 | 922 | 167 | 103 | 12 |
31 Dec 17 | 663 | 99 | 60 | 10 |
31 Dec 16 | 346 | 88 | 26 | 0 |
Quality Earnings: 1951 has high quality earnings.
Growing Profit Margin: 1951's current net profit margins (10.7%) are higher than last year (6%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 1951's earnings have declined by 6.3% per year over the past 5 years.
Accelerating Growth: 1951's earnings growth over the past year (101.1%) exceeds its 5-year average (-6.3% per year).
Earnings vs Industry: 1951 earnings growth over the past year (101.1%) exceeded the Healthcare industry -16.9%.
Return on Equity
High ROE: 1951's Return on Equity (3.1%) is considered low.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2025/01/31 17:54 |
End of Day Share Price | 2025/01/28 00:00 |
Earnings | 2024/06/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Jinxin Fertility Group Limited is covered by 29 analysts. 14 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Sharon Shi | BOCI Research Ltd. |
Ethan Cui | BofA Global Research |
Qianyi Li | China International Capital Corporation Limited |